BioCentury | Apr 5, 2019
Tools & Techniques

Second shot for shRNA

...lentiviral vectors to integrate shRNA constructs into genomic DNA. It was developed by the company’s Dharmacon...
BioCentury | Sep 1, 2017
Financial News

Horizon raises L80M in placing

...of 39 million shares in a placing. In July, Horizon said it will purchase the Dharmacon...
...million in cash and $35 million in Horizon stock. The offering closed on Aug. 31. Dharmacon...
BioCentury | Aug 23, 2017
Financial News

Horizon raises £80M in placing

...of 39 million shares in a placing. In July, Horizon said it will purchase the Dharmacon...
...General Electric Co. (NYSE:GE) for $50 million in cash and $35 million in Horizon stock. Dharmacon...
BioCentury | Oct 29, 2007
Company News

Lentigen, Thermo Fisher deal

...RNAi to create permanent gene silencing in research cell lines. The platform, called Thermo Scientific Dharmacon...
BioCentury | Jul 2, 2007
Company News

CytRx management update

...of technology development at CYTR's Rxi Pharmaceuticals Corp. subsidiary, formerly director of technology development at Dharmacon Inc. WIR...
BioCentury | Sep 4, 2006
Company News

Fisher, Lentigen deal

...FSH's Dharmacon Inc. subsidiary (Lafayette, Co.) partnered with Lentigen to develop and manufacture lentiviral expression reagents for...
...for RNAi research. The deal combines Dharmacon's gene silencing capabilities with Lentigen's LentiMax vector system. Dharmacon...
BioCentury | Jul 10, 2006
Company News

Abbott, Fisher deal

...FSH's Dharmacon Inc. subsidiary (Lafayette, Colo.) will use its SMARTselection and SMARTpool technologies to optimize siRNAs for...
BioCentury | Jun 12, 2006
Company News

amaxa, Fisher sales and marketing update

...The companies will co-promote siRNA libraries from FSH's Dharmacon Inc. subsidiary (Lafayette, Co.) with amaxa's Nucleofector siRNA...
BioCentury | Jan 9, 2006
Company News

Alnylam, Fisher deal

...ALNY granted FSH's Dharmacon Inc. subsidiary (Lafayette, Co.) a non-exclusive license to the Kreutzer-Limmer patents, which cover...
...the Kreutzer-Limmer patents, which cover siRNAs and their use to mediate RNAi in mammalian cells. Dharmacon...
BioCentury | Oct 24, 2005
Company News

Alcon Laboratories Inc., Fisher deal

...therapeutics for ophthalmic diseases. The deal combines Dharmacon's RNAi technologies with ACL's ophthalmic disease targets. Dharmacon...
Items per page:
1 - 10 of 45
BioCentury | Apr 5, 2019
Tools & Techniques

Second shot for shRNA

...lentiviral vectors to integrate shRNA constructs into genomic DNA. It was developed by the company’s Dharmacon...
BioCentury | Sep 1, 2017
Financial News

Horizon raises L80M in placing

...of 39 million shares in a placing. In July, Horizon said it will purchase the Dharmacon...
...million in cash and $35 million in Horizon stock. The offering closed on Aug. 31. Dharmacon...
BioCentury | Aug 23, 2017
Financial News

Horizon raises £80M in placing

...of 39 million shares in a placing. In July, Horizon said it will purchase the Dharmacon...
...General Electric Co. (NYSE:GE) for $50 million in cash and $35 million in Horizon stock. Dharmacon...
BioCentury | Oct 29, 2007
Company News

Lentigen, Thermo Fisher deal

...RNAi to create permanent gene silencing in research cell lines. The platform, called Thermo Scientific Dharmacon...
BioCentury | Jul 2, 2007
Company News

CytRx management update

...of technology development at CYTR's Rxi Pharmaceuticals Corp. subsidiary, formerly director of technology development at Dharmacon Inc. WIR...
BioCentury | Sep 4, 2006
Company News

Fisher, Lentigen deal

...FSH's Dharmacon Inc. subsidiary (Lafayette, Co.) partnered with Lentigen to develop and manufacture lentiviral expression reagents for...
...for RNAi research. The deal combines Dharmacon's gene silencing capabilities with Lentigen's LentiMax vector system. Dharmacon...
BioCentury | Jul 10, 2006
Company News

Abbott, Fisher deal

...FSH's Dharmacon Inc. subsidiary (Lafayette, Colo.) will use its SMARTselection and SMARTpool technologies to optimize siRNAs for...
BioCentury | Jun 12, 2006
Company News

amaxa, Fisher sales and marketing update

...The companies will co-promote siRNA libraries from FSH's Dharmacon Inc. subsidiary (Lafayette, Co.) with amaxa's Nucleofector siRNA...
BioCentury | Jan 9, 2006
Company News

Alnylam, Fisher deal

...ALNY granted FSH's Dharmacon Inc. subsidiary (Lafayette, Co.) a non-exclusive license to the Kreutzer-Limmer patents, which cover...
...the Kreutzer-Limmer patents, which cover siRNAs and their use to mediate RNAi in mammalian cells. Dharmacon...
BioCentury | Oct 24, 2005
Company News

Alcon Laboratories Inc., Fisher deal

...therapeutics for ophthalmic diseases. The deal combines Dharmacon's RNAi technologies with ACL's ophthalmic disease targets. Dharmacon...
Items per page:
1 - 10 of 45